rs672655

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000051.4(ATM):​c.2377-56A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.549 in 1,410,390 control chromosomes in the GnomAD database, including 217,313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 20115 hom., cov: 32)
Exomes 𝑓: 0.56 ( 197198 hom. )

Consequence

ATM
NM_000051.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.18
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 11-108258930-A-G is Benign according to our data. Variant chr11-108258930-A-G is described in ClinVar as [Benign]. Clinvar id is 1177614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-108258930-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.596 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATMNM_000051.4 linkc.2377-56A>G intron_variant Intron 15 of 62 ENST00000675843.1 NP_000042.3 Q13315A0A024R3C7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATMENST00000675843.1 linkc.2377-56A>G intron_variant Intron 15 of 62 NM_000051.4 ENSP00000501606.1 Q13315

Frequencies

GnomAD3 genomes
AF:
0.495
AC:
75137
AN:
151940
Hom.:
20105
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.276
Gnomad AMI
AF:
0.662
Gnomad AMR
AF:
0.607
Gnomad ASJ
AF:
0.640
Gnomad EAS
AF:
0.420
Gnomad SAS
AF:
0.602
Gnomad FIN
AF:
0.629
Gnomad MID
AF:
0.734
Gnomad NFE
AF:
0.567
Gnomad OTH
AF:
0.538
GnomAD4 exome
AF:
0.556
AC:
699635
AN:
1258332
Hom.:
197198
AF XY:
0.560
AC XY:
355690
AN XY:
635680
show subpopulations
Gnomad4 AFR exome
AF:
0.268
Gnomad4 AMR exome
AF:
0.629
Gnomad4 ASJ exome
AF:
0.612
Gnomad4 EAS exome
AF:
0.430
Gnomad4 SAS exome
AF:
0.597
Gnomad4 FIN exome
AF:
0.627
Gnomad4 NFE exome
AF:
0.557
Gnomad4 OTH exome
AF:
0.549
GnomAD4 genome
AF:
0.494
AC:
75167
AN:
152058
Hom.:
20115
Cov.:
32
AF XY:
0.503
AC XY:
37388
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.276
Gnomad4 AMR
AF:
0.607
Gnomad4 ASJ
AF:
0.640
Gnomad4 EAS
AF:
0.421
Gnomad4 SAS
AF:
0.604
Gnomad4 FIN
AF:
0.629
Gnomad4 NFE
AF:
0.567
Gnomad4 OTH
AF:
0.539
Alfa
AF:
0.511
Hom.:
2984
Bravo
AF:
0.481
Asia WGS
AF:
0.531
AC:
1844
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 63% of patients studied by a panel of primary immunodeficiencies. Number of patients: 60. Only high quality variants are reported. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Ataxia-telangiectasia syndrome Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
17
DANN
Benign
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs672655; hg19: chr11-108129657; COSMIC: COSV53757995; COSMIC: COSV53757995; API